TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03526159 — Predictive Biomarker (PRD): LAMC2 mRNA
Genes: LAMC2; LAMB2T; LAMNB2
Study NCT01287026 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03052088 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03052088 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04157647 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04191499 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04191499 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04191499 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03597659 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT04639440 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04639440 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT01873183 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00448383 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01144247 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03991975 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02875691 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02875691 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01006018 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02508129 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04503928 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00428116 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00758992 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00758992 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03284099 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03284099 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01292902 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT04787679 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04320667 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00587457 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04080544 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00008697 — Predictive Biomarker (PRD): RARA mRNA
Genes: RARA; NR1B1
Study NCT02148471 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03436056 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03436056 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03881787 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03881787 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01002053 — Predictive Biomarker (PRD): PTN mRNA
Genes: PTN; HBNF1; NEGF1
Study NCT02122692 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02122692 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01663883 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00668694 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00964704 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02557412 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02557412 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02557412 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT02557412 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT01927198 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05656261 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT01630759 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04377867 — Predictive Biomarker (PRD): LRBA mRNA
Genes: LRBA; BGL; CDC4L; LBA
Study NCT04377867 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT01792154 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01351402 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT04831424 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT04831424 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT00368017 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00368017 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00899210 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT04402853 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05341635 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01492699 — Predictive Biomarker (PRD): PRX mRNA
Genes: PRX; KIAA1620
Study NCT01522612 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01522612 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01522612 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01158729 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT02194465 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00006435 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01249534 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02049203 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02741284 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04466189 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT04466189 — Predictive Biomarker (PRD): XAF1 mRNA
Genes: XAF1; BIRC4BP; XIAPAF1
Study NCT04466189 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT04466189 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT04466189 — Predictive Biomarker (PRD): SMAD7 mRNA
Genes: SMAD7; MADH7; MADH8
Study NCT04466189 — Predictive Biomarker (PRD): SMAD4 mRNA
Genes: SMAD4; DPC4; MADH4
Study NCT04466189 — Predictive Biomarker (PRD): Ribonucleoside-diphosphate reductase large subunit
Genes: RRM1; RR1
Study NCT04466189 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT04466189 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04093362 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT01259973 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01259973 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT01422590 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03137914 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03287843 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03006471 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01009983 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03197636 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00223691 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02271178 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01480479 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03669185 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT03852537 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00422500 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT00128843 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03495921 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05088941 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03999749 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00683579 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04358952 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00894829 — Predictive Biomarker (PRD): TTPA mRNA
Genes: TTPA; TPP1
Study NCT03597919 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03624309 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03624309 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT03507101 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study NCT02469532 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03834168 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT03834168 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03434262 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study NCT04860180 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01114607 — Predictive Biomarker (PRD): CCR9 mRNA
Genes: CCR9; GPR28
Study NCT03504683 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01141205 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01915745 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03903211 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02892929 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03077776 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03378752 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04585880 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03412799 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study NCT01571791 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00259233 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT00259233 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00651846 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT01808573 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00529035 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02463383 — Predictive Biomarker (PRD): PPARG mRNA
Genes: PPARG; NR1C3
Study NCT01148615 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01148615 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03442361 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT04489368 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT00267540 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02668068 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02668068 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT02842138 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04225910 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03164681 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02616185 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02302989 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01083082 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03716427 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03716427 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03716427 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03716427 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02421523 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02827695 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04125459 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT00022334 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT02304497 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT01392781 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01693510 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01228578 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03007992 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03007992 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01960023 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01960023 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT01960023 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01960023 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02015065 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT02015065 — Safety Biomarker (SAF): Succinate dehydrogenase
Genes: SDHD
Study NCT03373370 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT02597127 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03844074 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01763866 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03363217 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT03363217 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study NCT04196205 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02388841 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02072616 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01471990 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT03349983 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT02833220 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01696279 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT00208975 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00036426 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04578106 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01314625 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03636685 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT03636685 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT01004744 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01088269 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04535154 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00396812 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00396812 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02539355 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02539355 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02539355 — Safety Biomarker (SAF): Interleukin 1
Study NCT02539355 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04765631 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03933514 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02735538 — Predictive Biomarker (PRD): RUNX2 mRNA
Genes: RUNX2; AML3; CBFA1; OSF2; PEBP2A
Study NCT00841828 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05286346 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01520870 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00980785 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02111044 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT01134666 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03782636 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03131804 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03493256 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT02058485 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03776149 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03846583 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03128385 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT02142439 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03897868 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01949727 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03896113 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT03896113 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study NCT00325650 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04393324 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04274257 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01202591 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT03790397 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01601314 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT01017627 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study NCT02488525 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02210104 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02210104 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02210104 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02203890 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04150887 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT02994680 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02994680 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT01517958 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT01212289 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00959751 — Predictive Biomarker (PRD): NXN mRNA
Genes: NXN; NRX
Study NCT00879177 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT00879177 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01049646 — Predictive Biomarker (PRD): APLNR mRNA
Genes: APLNR; AGTRL1; APJ
Study NCT02813980 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03542799 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01295580 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03520725 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01558843 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00550030 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04358055 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00213980 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01168401 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT01446185 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01528085 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01528085 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03728712 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03095287 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02749734 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT03629301 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01668043 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01115231 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study NCT01199614 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02665117 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT02665117 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT03476642 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01245348 — Predictive Biomarker (PRD): SULT4A1 mRNA
Genes: SULT4A1; SULTX3
Study NCT04811547 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01069211 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01069211 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02016118 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT02016118 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03912272 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02623595 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00397579 — Predictive Biomarker (PRD): IL3RA mRNA
Genes: IL3RA; IL3R
Study NCT01137786 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01699984 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT01869309 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study NCT00689156 — Predictive Biomarker (PRD): TOP2A mRNA
Genes: TOP2A; TOP2
Study NCT01909102 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00084630 — Pharmacodynamic Biomarker (PDY): Platelet-derived growth factor B
Genes: PDGFB; PDGF2; SIS